Wird geladen...
Development of Sustained Release “NanoFDC (Fixed Dose Combination)” for Hypertension – An Experimental Study
OBJECTIVES: The present study was planned to formulate, characterize and evaluate the pharmacokinetics of a novel “NanoFDC” comprising three commonly prescribed anti-hypertensive drugs, hydrochlorothiazide (a diuretic), candesartan (ARB) and amlodipine (a calcium channel blocker). BASIC METHODS: The...
Gespeichert in:
| Veröffentlicht in: | PLoS One |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Public Library of Science
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457799/ https://ncbi.nlm.nih.gov/pubmed/26047011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0128208 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|